PROF - Profound Medical Corp

https://www.profoundmedical.com

Momentum: Bearish

Recent News

Profound Medical ( PROF ) Reports Q2 Loss, Misses Revenue Estimates

Zacks Commentary • 1 month ago • score: 0.05

Profound Medical (PROF) delivered earnings and revenue surprises of -20.93% and -25.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Profound Medical Corp. The company is headquartered in Mississauga, Canada.

52W High

$9.17

52W Low

$3.90

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.22

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-5.75

EV/Revenue (<3 favorable)

8.01

P/S (TTM) (<3 favorable)

10.56

P/B (<3 favorable)

3.15

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

17.35%

Institutions (25–75% balanced)

45.98%

Shares Outstanding

30,053,100

Float

27,569,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

11,840,000

Gross Profit (TTM)

8,221,000

EPS (TTM)

-1.45

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-6.24%

ROE (TTM) (>15% strong)

-1.04%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.01

Momentum

Bearish momentum

Value

-0.4042

-0.4171

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025